loadpatents
name:-0.018948078155518
name:-0.016064882278442
name:-0.0060758590698242
Herlyn; Meenhard Patent Filings

Herlyn; Meenhard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Herlyn; Meenhard.The latest application filed is for "methods and compositions for treating melanoma".

Company Profile
2.13.13
  • Herlyn; Meenhard - Wynnewood PA
  • Herlyn; Meenhard - Philadelphia PA
  • Herlyn; Meenhard - Wynnwood PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods and Compositions for Treating Melanoma
App 20220177548 - Somasundaram; Rajasekharan ;   et al.
2022-06-09
Methods and compositions for treating melanoma
Grant 11,208,468 - Somasundaram , et al. December 28, 2
2021-12-28
Humanized Mouse Model
App 20210153484 - Somasundaram; Rajasekharan ;   et al.
2021-05-27
Methods and Compositions for Treating Melanoma
App 20190276517 - Somasundaram; Rajasekharan ;   et al.
2019-09-12
Combination Therapies Targeting Mitochondrial Biogenesis For Cancer Therapy
App 20180228740 - Zhang; Gao ;   et al.
2018-08-16
Methods and Compositions for Treating or Diagnosing Melanoma
App 20150166646 - Wang; Tao ;   et al.
2015-06-18
Methods for preparation of human hair-follicle derived multipotent adult stem cells
Grant 8,999,706 - Xu , et al. April 7, 2
2015-04-07
Compositions Containing JARID1B Inhibitors and Methods for Treating Cancer
App 20120164148 - Roesch; Alexander O. ;   et al.
2012-06-28
Method for Dedifferentiating Melanocytes
App 20110177042 - Herlyn; Meenhard ;   et al.
2011-07-21
Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic T lymphocyte activity
Grant 7,544,465 - Herlyn , et al. June 9, 2
2009-06-09
Multipotent adult stem cells
App 20090130065 - Xu; Xiaowei ;   et al.
2009-05-21
Organotypic intestinal culture and methods of use thereof
Grant 7,217,570 - Herlyn , et al. May 15, 2
2007-05-15
Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic t lymphocyte activity
App 20060073469 - Herlyn; Dorothee ;   et al.
2006-04-06
Organotypic intestinal culture and methods of use thereof
App 20040175367 - Herlyn, Meenhard ;   et al.
2004-09-09
Regulation of human skin healing
App 20040031067 - Herlyn, Meenhard ;   et al.
2004-02-12
Methods for inducing localized vascular development and enhancing the repair of a wound in the mammamian dermis
Grant 6,486,133 - Herlyn , et al. November 26, 2
2002-11-26
Methods for inhibition of tumorigenic properties of melanoma cells
App 20020165188 - Herlyn, Meenhard ;   et al.
2002-11-07
Novel genetic suppressor elements and methods of making the same
App 20020081711 - Herlyn, Meenhard ;   et al.
2002-06-27
WT1 monoclonal antibodies and methods of use therefor
Grant 5,633,142 - Herlyn , et al. May 27, 1
1997-05-27
WT1 monoclonal antibodies
Grant 5,622,835 - Herlyn , et al. April 22, 1
1997-04-22
Method of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425
Grant 5,470,571 - Herlyn , et al. November 28, 1
1995-11-28
Monoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodies
Grant 4,849,509 - Thurin , et al. July 18, 1
1989-07-18
Diagnostic method for detection of neural crest disease
Grant 4,786,593 - Ross , et al. November 22, 1
1988-11-22
Lewis blood group phenotype assay
Grant 4,607,009 - Steplewski , et al. August 19, 1
1986-08-19
Detection of colorectal carcinoma
Grant 4,471,057 - Koprowski , et al. September 11, 1
1984-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed